Immediate Implants: to Graft or Not to Graft, That is the Question.
TAOM-TA
Flapless Immediate Implants in Type 1 Alveoli: Soft Tissue Alterations Following a Trimodal Approach With or Without Modifying Osseous and Mucosal Compartments (TAOM vs TA) in the Aesthetic Zone: A Comparative Prospective Study.
1 other identifier
interventional
31
1 country
1
Brief Summary
The aim was to compare two protocols for immediate implants with fixed provisional restoration, no grafting (trimodal approach=TA) versus grafting both osseous gap and peri-implant mucosa (trimodal approach with modification of the osseous and mucosal compartments =TAOM) by measuring the soft tissue changes overtime. The periodontal phenotype was registered, to investigate a relationship between its thickness and the clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 19, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedJuly 3, 2023
May 1, 2023
6.9 years
May 19, 2023
June 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Distance from measuring points on the reference stent to gingival zenith of the implant restoration in tenths of a milimetre by means of a precision digital calliper.
Vertical midfacial soft tissue change from baseline (before tooth extraction) to 12 months following implant placement.
12 months
Secondary Outcomes (2)
Distance from measuring points on the reference stent to mesial and distal papillae of the implant restoration in tenths of a milimetres by means of a precision digital calliper.
12 months
Periodontal thickness at 5mm apical to the gingival margin in tenths of a milimetre.
Baseline
Study Arms (2)
Trimodal Approach with Osseous and Mucosal compartment modification: TAOM
EXPERIMENTALFlapless immediate implant placement and provisional restoration with alveolar filling and connective tissue graft.
Trimodal Approach: TA
ACTIVE COMPARATORFlapless immediate implant placement and provisional restoration.
Interventions
In the TAOM group, the gap between the implant and the facial bone wall was grafted with inorganic bovine bone (Geistlich Bio-Oss®; Geistlich Pharma AG, Wolhusen, Switzerland) and, in addition, a connective tissue graft (CTG) was placed submucosally on the labial bone plate by means of an envelope technique.
Eligibility Criteria
You may qualify if:
- Need for tooth extraction in the anterior maxilla (13-23) due to cavities, internal resorption, fractures, restorative problems, endodontic complications and prosthetic reasons.
- The failing tooth has adjacent and opposing natural teeth
- Adequate oral hygiene (Bleeding on probing \<20%; Plaque index \<20%);
- Absence of active and uncontrolled periodontal disease
- Sufficient mesial-distal and interocclusal space for implant placement and definitive restoration
- Sufficient interocclusal space to design a non-occluding provisional restoration
You may not qualify if:
- Systemic metabolic or osseous disease that could compromise peri-implant tissue healing.
- Acute infection in the treatment area
- Absence of one or both adjacent teeth
- Non-integrity of the buccal bone wall (dehiscence or fenestration) observed during surgery, or when tooth extraction has altered the integrity of the osseous and gingival architecture
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maria Del Rosario Rioboo Crespo
Madrid, 28003, Spain
Study Officials
- PRINCIPAL INVESTIGATOR
Gustavo G Cabello
Private Practice, Málaga, Spain
- PRINCIPAL INVESTIGATOR
Javier J Fabrega
Private Practice, Madrid, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2023
First Posted
July 3, 2023
Study Start
April 1, 2009
Primary Completion
March 1, 2016
Study Completion
February 1, 2020
Last Updated
July 3, 2023
Record last verified: 2023-05